[1]
2017. Psoriasis Therapies and the Risk of Cutaneous Malignancy. SKIN The Journal of Cutaneous Medicine. 1, 2 (Aug. 2017), 55–63. DOI:https://doi.org/10.25251/skin.1.2.1.